Peer Review reports
From: HOX and PBX gene dysregulation as a therapeutic target in glioblastoma multiforme
Original Submission | ||
---|---|---|
8 Sep 2021 | Submitted | Original manuscript |
11 Oct 2021 | Reviewed | Reviewer Report |
28 Nov 2021 | Reviewed | Reviewer Report - Carl-friedrich Classen |
25 Jan 2022 | Author responded | Author comments - Hardev Pandha |
Resubmission - Version 2 | ||
25 Jan 2022 | Submitted | Manuscript version 2 |
22 Feb 2022 | Author responded | Author comments - Hardev Pandha |
Resubmission - Version 3 | ||
22 Feb 2022 | Submitted | Manuscript version 3 |
7 Mar 2022 | Author responded | Author comments - Hardev Pandha |
Resubmission - Version 4 | ||
7 Mar 2022 | Submitted | Manuscript version 4 |
8 Mar 2022 | Author responded | Author comments - Hardev Pandha |
Resubmission - Version 5 | ||
8 Mar 2022 | Submitted | Manuscript version 5 |
18 Mar 2022 | Reviewed | Reviewer Report |
Resubmission - Version 6 | ||
Submitted | Manuscript version 6 | |
Publishing | ||
21 Mar 2022 | Editorially accepted | |
13 Apr 2022 | Article published | 10.1186/s12885-022-09466-8 |
You can find further information about peer review here.